pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-552 |
Genomic Coordinates | chr1: 34669599 - 34669694 |
Synonyms | MIRN552, hsa-mir-552, MIR552 |
Description | Homo sapiens miR-552 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-552-5p | ||||||||||||||||||||||||
Sequence | 25| GUUUAACCUUUUGCCUGUUGG |45 | ||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | XRRA1 | ||||||||||||||||||||
Synonyms | - | ||||||||||||||||||||
Description | X-ray radiation resistance associated 1 | ||||||||||||||||||||
Transcript | NM_182969 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on XRRA1 | |||||||||||||||||||||
3'UTR of XRRA1 (miRNA target sites are highlighted) |
>XRRA1|NM_182969|3'UTR 1 AGCTGTGCATGGGGGCTGTGTGCACCACCCGGCCTGTGCCCCAGCTCTCCCCGAGGGCTCTGTGCCCTGGACCGCACCTC 81 AAGGTTGACCAGCCGGCCACAGGCCTCAGAGCTCAGCTGGGCCCCACTTGCTGGCCACAAGGTGGCATCCCCTTGTCAGG 161 ATCTCCCCTCCTTGGCCCAGGCATGACCTGGTGCCTGGCCCAGCGGCAATAAAGAGTGGGTGCACAGGGCAATAGACTGG 241 GTGCCACATGCATTCTTTCTTGGAACCCAGGCCACAGCAGCATTGTCACACTTCCCTCTAAAAATGGTTTTCCAGTTCAG 321 ATGCAACAGGGATACATTTGTTCTCTGTTGTATGAGAAACTGACACCAAGGGGATCTTAACAAATTCCTGAACAATGGCT 401 CCAAAAAAGGGTATTTTTAAAAACCAGATCTTGTGAGTACAGCCCTAATGTGCAGGGACAGTGTCATCCTGTATATTCGT 481 TCTTTACTCAGACTCTTTCTTGGTTCCTTCATTAGGAGCATGAATGGTTGAATGTGAACATGACAGTAAATTGGAGCAAA 561 CTGTAAACTGGACATAACTTATGCCAAAAGACGTAGTTGTACACCATGGAAACCCCATCCCTGCTCCTAATCTCTACTGC 641 CATTCTGAATGCCAAAGCAAGACATCCAACATGGGGCATCTCCCAGAGCACATACAGCACCAAAAATCCACACACAGCCT 721 AAGCTTAACCCATGTTTTTGTCTGAGATTGTTCACCAGAGACAAGACTCTGACTATAAACAGAACATCCACTTTCATGAG 801 TTTCCTTTACTGTATTCTCAACTTGGGCCTTGCTTCAAGCAGGCAAACATACATTGAAGAATGCACTTTGGTACTGTTTA 881 AATAACAACACATCAGCCCACTTGATTCCATGCCATGTCCTTGCTGACAGAAACATCCCCAACAGGGCATGCCCTGGTCC 961 AAGTCCTCTGTCTTTGTCAAAATGCTCTTCTGATGAGTTGGAGAGGAGGCAGCCAGCAGTGGCAGTCCACAAGGATCCAG 1041 GTACCTTCTCCAATCCTAAAGCAGACAGCAGGTTGAATAAAACCAATACACAACCTATTTTCTAGGCAGGAGGGGAAAAG 1121 GCCCTTAGGACAATAATATTTGTACAAAGAGTTGAGAGTAAACAAACAGTGTATCAGGTTCAAAAAAAAAAAAACTATTC 1201 GTTGGCATTTAAATTTTTTTCCCTTGCATAGTATCTATTCTCTCACTAGGACTTTTAAGTGCTCTGCTGGAGGCTCAGCG 1281 TTGGTAATACCATGTTTGATGCAAACTTGAACCCAATGCTCTCATTGGTGGCACAGCTTTGGAGGGTGGTGGCCCCAAGA 1361 AGGGGCAATCTGCCTGCTGCTATATTAATCTGGAACCAGGGCCAACAGCTACTCTTGAACTATGGTATTTGAAGAGCGAG 1441 TTCATTGCCTGTTTTACCTTAAATGACAGGAAAGGAAGATGAACAAACCTTGCTTTGCCTTGGCTTCAAACTAGTTCTTG 1521 ATTTAAGACACCAGAAAGGGAGAGAGGGAGTCTGCTTAGAGTTTGAGGTTGCCTCTCACAAGATGACAGTTAAAAGTTGC 1601 CACCTTACTTAAAAGGCATTAAGGAGGCATTTACTCACAAAGGAGAGAGAGTAAATTTTTTTCTTAAGAGGAAAAAAATA 1681 CTGATAATACATAGAACAATCTGCACATCCAGTCTTGGCACTTTTTCCAATTTGACTGATCTCTAAACTGGTGACCCTTG 1761 CATATATCTTAGTCTCTTTTCTACAATCTTCTTCAGAAAGCTACAGCAGCTAACAATCATGTATAAAGATGCATTTCCTA 1841 GATCATCTTCAGAAGAAAATCTCTTCAGCACTTTCCCTAGAATCTGTCTCCTGACCACCCCGCCCCAGACCTGCTTTCTC 1921 TTTTGAGAATTCATAACCAGGTATGTTTAGATACCAGTTCAAAAGACCACTCTATGGGTTGATGAGGAAAAGGCTGCCTG 2001 AGGACAATTTAAGACCATAATGAGTTTCCAATTTTTAAAGAAAATTTGGCTAGCTGGCTTTTAATTCTTAATTAAAATCA 2081 TTAAATTTAATTAAAATTATTCCAATCAAAATATATCACTTTCCAAGATTCCACATTCATATTACTTACTTATACTATGG 2161 AGACTTTCTCTACCTGAGCATGTATTCAGGGGCTATAGGTACATTTAACTCTAACTAACTGAAAAAAATCAGGAAGAAAA 2241 AACTATTAAAATAAAATAACCTCCTAAATCATTTGGGGGTATCCCCATCAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HeLa | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in Chi_ControlB_2A8_130_50. RNA binding protein: AGO. Condition:HeLa cell Control B
... - Chi SW; Zang JB; Mele A; Darnell RB, 2009, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Chi SW; Zang JB; Mele A; Darnell RB - Nature, 2009
MicroRNAs (miRNAs) have critical roles in the regulation of gene expression; however, as miRNA activity requires base pairing with only 6-8 nucleotides of messenger RNA, predicting target mRNAs is a major challenge. Recently, high-throughput sequencing of RNAs isolated by crosslinking immunoprecipitation (HITS-CLIP) has identified functional protein-RNA interaction sites. Here we use HITS-CLIP to covalently crosslink native argonaute (Ago, also called Eif2c) protein-RNA complexes in mouse brain. This produced two simultaneous data sets-Ago-miRNA and Ago-mRNA binding sites-that were combined with bioinformatic analysis to identify interaction sites between miRNA and target mRNA. We validated genome-wide interaction maps for miR-124, and generated additional maps for the 20 most abundant miRNAs present in P13 mouse brain. Ago HITS-CLIP provides a general platform for exploring the specificity and range of miRNA action in vivo, and identifies precise sequences for targeting clinically relevant miRNA-mRNA interactions.
LinkOut: [PMID: 19536157]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | BC-3 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM796040. RNA binding protein: AGO2. Condition:4-Thiouridine
... - Gottwein E; Corcoran DL; Mukherjee N; et al., 2011, Cell host & microbe. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Gottwein E; Corcoran DL; Mukherjee N; et al. - Cell host & microbe, 2011
Primary effusion lymphoma (PEL) is caused by Kaposi's sarcoma-associated herpesvirus (KSHV) and frequently also harbors Epstein-Barr virus (EBV). The expression of KSHV- and EBV-encoded microRNAs (miRNAs) in PELs suggests a role for these miRNAs in latency and lymphomagenesis. Using PAR-CLIP, a technology which allows the direct and transcriptome-wide identification of miRNA targets, we delineate the target sites for all viral and cellular miRNAs expressed in PEL cell lines. The resulting data set revealed that KSHV miRNAs directly target more than 2000 cellular mRNAs, including many involved in pathways relevant to KSHV pathogenesis. Moreover, 58% of these mRNAs are also targeted by EBV miRNAs, via distinct binding sites. In addition to a known viral analog of cellular miR-155, we show that KSHV encodes a viral miRNA that mimics cellular miR-142-3p function. In summary, this study identifies an extensive list of KSHV miRNA targets, which are likely to influence viral replication and pathogenesis.
LinkOut: [PMID: 22100165]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | Hela |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1048187. RNA binding protein: AGO2. Condition:Hela_AGO2_CLIP_control
... - Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al., 2013, Cell. |
Article |
- Xue Y; Ouyang K; Huang J; Zhou Y; Ouyang H; et al. - Cell, 2013
The induction of pluripotency or trans-differentiation of one cell type to another can be accomplished with cell-lineage-specific transcription factors. Here, we report that repression of a single RNA binding polypyrimidine-tract-binding (PTB) protein, which occurs during normal brain development via the action of miR-124, is sufficient to induce trans-differentiation of fibroblasts into functional neurons. Besides its traditional role in regulated splicing, we show that PTB has a previously undocumented function in the regulation of microRNA functions, suppressing or enhancing microRNA targeting by competitive binding on target mRNA or altering local RNA secondary structure. A key event during neuronal induction is the relief of PTB-mediated blockage of microRNA action on multiple components of the REST complex, thereby derepressing a large array of neuronal genes, including miR-124 and multiple neuronal-specific transcription factors, in nonneuronal cells. This converts a negative feedback loop to a positive one to elicit cellular reprogramming to the neuronal lineage.
LinkOut: [PMID: 23313552]
|
Experimental Support 4 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293S |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084045. RNA binding protein: AGO2. Condition:CLIP_arsenite_rep3
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
HITS-CLIP data was present in GSM1084067. RNA binding protein: AGO2. Condition:CLIP_emetine_SantaCruzAb
HITS-CLIP data was present in GSM1084069. RNA binding protein: AGO2. Condition:CLIP_emetine_SigmaAb
HITS-CLIP data was present in GSM1084075. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep1_SantaCruzAb
HITS-CLIP data was present in GSM1084078. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_AbnovaAb
HITS-CLIP data was present in GSM1084079. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_AbnovaAb
HITS-CLIP data was present in GSM1084080. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_SantaCruzAb
HITS-CLIP data was present in GSM1084081. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_SantaCruzAb
HITS-CLIP data was present in GSM1084082. RNA binding protein: AGO2. Condition:CLIP_nohippuristanol_rep2_SigmaAb
HITS-CLIP data was present in GSM1084083. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_SigmaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset Chi_ControlB_2A8_130_50 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | HeLa / HeLa cell Control B |
Location of target site | ENST00000527087.1 | 3UTR | UGGUUAAAAAAAAAAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 19536157 / Chi_HITSCLIP |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1048187 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | Hela / Hela_AGO2_CLIP_control |
Location of target site | ENST00000527087.1 | 3UTR | UGGUUAAAAAAAAAAAAAAAAAAAAGUGGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23313552 / GSE42701 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1084045 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_arsenite_rep3 |
Location of target site | ENST00000527087.1 | 3UTR | UUUGGUUAAAAAAAAAAAAAAAAAAAAGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1084065 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000527087.1 | 3UTR | UGGUUAAAAAAAAAAAAAAAAAAAAGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM1084067 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_SantaCruzAb |
Location of target site | ENST00000527087.1 | 3UTR | UUAAAAAAAAAAAAAAAAAAAAGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM1084069 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_SigmaAb |
Location of target site | ENST00000527087.1 | 3UTR | UUUGGUUAAAAAAAAAAAAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1084075 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep1_SantaCruzAb |
Location of target site | ENST00000527087.1 | 3UTR | UGGUUAAAAAAAAAAAAAAAAAAAAGUGGGGGCGG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM1084078 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000527087.1 | 3UTR | UGGUUAAAAAAAAAAAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1084079 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000527087.1 | 3UTR | UGGUUAAAAAAAAAAAAAAAAAAAAGUGGGGGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 10 for dataset GSM1084081 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_SantaCruzAb |
Location of target site | ENST00000527087.1 | 3UTR | UUUGGUUAAAAAAAAAAAAAAAAAAAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 11 for dataset GSM1084082 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_nohippuristanol_rep2_SigmaAb |
Location of target site | ENST00000527087.1 | 3UTR | UGGUUAAAAAAAAAAAAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 12 for dataset GSM1084083 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_SigmaAb |
Location of target site | ENST00000527087.1 | 3UTR | UGGUUAAAAAAAAAAAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 13 for dataset GSM796040 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | BC-3 / 4-Thiouridine |
Location of target site | ENST00000527087.1 | 3UTR | UUGGUUAAAAAAAAAAAAAAAA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 22100165 / GSE32109 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
118 hsa-miR-552-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT060509 | PPP6R3 | protein phosphatase 6 regulatory subunit 3 | 2 | 2 | ||||||||
MIRT061011 | C1ORF21 | chromosome 1 open reading frame 21 | 2 | 6 | ||||||||
MIRT090823 | MBNL1 | muscleblind like splicing regulator 1 | 2 | 4 | ||||||||
MIRT126569 | MASTL | microtubule associated serine/threonine kinase like | 2 | 2 | ||||||||
MIRT147688 | CBX4 | chromobox 4 | 2 | 4 | ||||||||
MIRT191746 | ELMSAN1 | ELM2 and Myb/SANT domain containing 1 | 2 | 4 | ||||||||
MIRT202397 | GPCPD1 | glycerophosphocholine phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT231334 | XRRA1 | X-ray radiation resistance associated 1 | 2 | 8 | ||||||||
MIRT241355 | SLC16A1 | solute carrier family 16 member 1 | 2 | 2 | ||||||||
MIRT280627 | BCL11B | B-cell CLL/lymphoma 11B | 2 | 2 | ||||||||
MIRT287408 | GPATCH8 | G-patch domain containing 8 | 2 | 2 | ||||||||
MIRT314310 | FCHO2 | FCH domain only 2 | 2 | 2 | ||||||||
MIRT321751 | ANKRD46 | ankyrin repeat domain 46 | 2 | 2 | ||||||||
MIRT329335 | ETF1 | eukaryotic translation termination factor 1 | 2 | 2 | ||||||||
MIRT346611 | PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 2 | 6 | ||||||||
MIRT349189 | ZNF557 | zinc finger protein 557 | 2 | 2 | ||||||||
MIRT357416 | HNRNPA0 | heterogeneous nuclear ribonucleoprotein A0 | 2 | 2 | ||||||||
MIRT359670 | NUS1 | NUS1 dehydrodolichyl diphosphate synthase subunit | 2 | 2 | ||||||||
MIRT442751 | PLAG1 | PLAG1 zinc finger | 2 | 6 | ||||||||
MIRT446639 | SPTY2D1 | SPT2 chromatin protein domain containing 1 | 2 | 2 | ||||||||
MIRT450820 | KCNB1 | potassium voltage-gated channel subfamily B member 1 | 2 | 2 | ||||||||
MIRT452304 | EIF5AL1 | eukaryotic translation initiation factor 5A-like 1 | 2 | 2 | ||||||||
MIRT468814 | RSRC2 | arginine and serine rich coiled-coil 2 | 2 | 6 | ||||||||
MIRT471878 | NUFIP2 | NUFIP2, FMR1 interacting protein 2 | 2 | 6 | ||||||||
MIRT472681 | MYCBP | MYC binding protein | 2 | 4 | ||||||||
MIRT473123 | MLLT10 | MLLT10, histone lysine methyltransferase DOT1L cofactor | 2 | 2 | ||||||||
MIRT477434 | EML4 | echinoderm microtubule associated protein like 4 | 2 | 4 | ||||||||
MIRT501254 | SECISBP2L | SECIS binding protein 2 like | 2 | 2 | ||||||||
MIRT501586 | PLCG1 | phospholipase C gamma 1 | 2 | 2 | ||||||||
MIRT503371 | SCAMP1 | secretory carrier membrane protein 1 | 2 | 2 | ||||||||
MIRT504358 | ARID1B | AT-rich interaction domain 1B | 2 | 6 | ||||||||
MIRT504421 | SHC4 | SHC adaptor protein 4 | 2 | 6 | ||||||||
MIRT505497 | SRSF1 | serine and arginine rich splicing factor 1 | 2 | 4 | ||||||||
MIRT505792 | RSBN1 | round spermatid basic protein 1 | 2 | 8 | ||||||||
MIRT506471 | NAA25 | N(alpha)-acetyltransferase 25, NatB auxiliary subunit | 2 | 4 | ||||||||
MIRT507372 | EPS8 | epidermal growth factor receptor pathway substrate 8 | 2 | 2 | ||||||||
MIRT510850 | RAN | RAN, member RAS oncogene family | 2 | 8 | ||||||||
MIRT510986 | PER1 | period circadian clock 1 | 2 | 4 | ||||||||
MIRT512987 | SEZ6L | seizure related 6 homolog like | 2 | 4 | ||||||||
MIRT514937 | GPR141 | G protein-coupled receptor 141 | 2 | 2 | ||||||||
MIRT522131 | NRBF2 | nuclear receptor binding factor 2 | 2 | 6 | ||||||||
MIRT524300 | CTC1 | CST telomere replication complex component 1 | 2 | 8 | ||||||||
MIRT526363 | LSAMP | limbic system-associated membrane protein | 2 | 2 | ||||||||
MIRT526441 | RBM48 | RNA binding motif protein 48 | 2 | 2 | ||||||||
MIRT526534 | MDM2 | MDM2 proto-oncogene | 2 | 4 | ||||||||
MIRT528065 | HES2 | hes family bHLH transcription factor 2 | 2 | 2 | ||||||||
MIRT531043 | TIPARP | TCDD inducible poly(ADP-ribose) polymerase | 2 | 2 | ||||||||
MIRT532313 | FKBP9 | FK506 binding protein 9 | 2 | 4 | ||||||||
MIRT533196 | WASF3 | WAS protein family member 3 | 2 | 4 | ||||||||
MIRT535701 | NAV1 | neuron navigator 1 | 2 | 5 | ||||||||
MIRT536791 | HNRNPA2B1 | heterogeneous nuclear ribonucleoprotein A2/B1 | 2 | 2 | ||||||||
MIRT537228 | GALNT7 | polypeptide N-acetylgalactosaminyltransferase 7 | 2 | 6 | ||||||||
MIRT538247 | CUX2 | cut like homeobox 2 | 2 | 2 | ||||||||
MIRT538476 | CLOCK | clock circadian regulator | 2 | 2 | ||||||||
MIRT538798 | C2CD5 | C2 calcium dependent domain containing 5 | 2 | 2 | ||||||||
MIRT539031 | ATXN7L1 | ataxin 7 like 1 | 2 | 2 | ||||||||
MIRT542043 | SLC25A46 | solute carrier family 25 member 46 | 2 | 2 | ||||||||
MIRT543093 | TNFRSF11A | TNF receptor superfamily member 11a | 2 | 2 | ||||||||
MIRT543545 | INTS2 | integrator complex subunit 2 | 2 | 2 | ||||||||
MIRT554332 | SH3GLB1 | SH3 domain containing GRB2 like, endophilin B1 | 2 | 4 | ||||||||
MIRT556070 | MRFAP1 | Morf4 family associated protein 1 | 2 | 2 | ||||||||
MIRT558125 | ENPP4 | ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative) | 2 | 2 | ||||||||
MIRT559132 | BTG3 | BTG anti-proliferation factor 3 | 2 | 4 | ||||||||
MIRT559423 | ASF1A | anti-silencing function 1A histone chaperone | 2 | 2 | ||||||||
MIRT560026 | ZNF780A | zinc finger protein 780A | 2 | 2 | ||||||||
MIRT566128 | RACGAP1 | Rac GTPase activating protein 1 | 2 | 2 | ||||||||
MIRT566441 | PHF13 | PHD finger protein 13 | 2 | 2 | ||||||||
MIRT568541 | AKT3 | AKT serine/threonine kinase 3 | 2 | 2 | ||||||||
MIRT568626 | ACVR2A | activin A receptor type 2A | 2 | 2 | ||||||||
MIRT576599 | Nav1 | neuron navigator 1 | 2 | 4 | ||||||||
MIRT609438 | USP27X | ubiquitin specific peptidase 27, X-linked | 2 | 2 | ||||||||
MIRT611441 | NRIP3 | nuclear receptor interacting protein 3 | 2 | 2 | ||||||||
MIRT613007 | GABRB1 | gamma-aminobutyric acid type A receptor beta1 subunit | 2 | 2 | ||||||||
MIRT614149 | CEP97 | centrosomal protein 97 | 2 | 2 | ||||||||
MIRT614580 | LHX1 | LIM homeobox 1 | 2 | 2 | ||||||||
MIRT615631 | ATF6 | activating transcription factor 6 | 2 | 4 | ||||||||
MIRT616115 | NDUFS1 | NADH:ubiquinone oxidoreductase core subunit S1 | 2 | 2 | ||||||||
MIRT620351 | WDR75 | WD repeat domain 75 | 2 | 2 | ||||||||
MIRT621733 | TNPO2 | transportin 2 | 2 | 2 | ||||||||
MIRT623718 | HACE1 | HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT626107 | MYLIP | myosin regulatory light chain interacting protein | 2 | 2 | ||||||||
MIRT630779 | CRLS1 | cardiolipin synthase 1 | 2 | 2 | ||||||||
MIRT632585 | PLCL1 | phospholipase C like 1 (inactive) | 2 | 2 | ||||||||
MIRT635161 | HOXD12 | homeobox D12 | 2 | 2 | ||||||||
MIRT635878 | SIX3 | SIX homeobox 3 | 2 | 2 | ||||||||
MIRT636941 | LIMS3 | LIM zinc finger domain containing 3 | 2 | 2 | ||||||||
MIRT637007 | LIMS3L | LIM zinc finger domain containing 4 | 2 | 2 | ||||||||
MIRT639202 | LRRC9 | leucine rich repeat containing 9 | 2 | 4 | ||||||||
MIRT639388 | PKHD1 | PKHD1, fibrocystin/polyductin | 2 | 2 | ||||||||
MIRT639543 | SMCR7L | mitochondrial elongation factor 1 | 1 | 1 | ||||||||
MIRT642071 | FUT11 | fucosyltransferase 11 | 2 | 2 | ||||||||
MIRT642567 | GDPGP1 | GDP-D-glucose phosphorylase 1 | 2 | 2 | ||||||||
MIRT643035 | SNX24 | sorting nexin 24 | 2 | 2 | ||||||||
MIRT648372 | SMPD1 | sphingomyelin phosphodiesterase 1 | 2 | 2 | ||||||||
MIRT648529 | KIAA1143 | KIAA1143 | 2 | 2 | ||||||||
MIRT652184 | TRIM44 | tripartite motif containing 44 | 2 | 2 | ||||||||
MIRT652945 | SYNC | syncoilin, intermediate filament protein | 2 | 2 | ||||||||
MIRT657012 | KCNK5 | potassium two pore domain channel subfamily K member 5 | 2 | 2 | ||||||||
MIRT658993 | DIP2C | disco interacting protein 2 homolog C | 2 | 2 | ||||||||
MIRT659629 | CDKN2AIP | CDKN2A interacting protein | 2 | 2 | ||||||||
MIRT659769 | CCBE1 | collagen and calcium binding EGF domains 1 | 2 | 2 | ||||||||
MIRT660527 | ARIH1 | ariadne RBR E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT668526 | ERP44 | endoplasmic reticulum protein 44 | 2 | 2 | ||||||||
MIRT687184 | PRKAR1A | protein kinase cAMP-dependent type I regulatory subunit alpha | 2 | 2 | ||||||||
MIRT696280 | IER3IP1 | immediate early response 3 interacting protein 1 | 2 | 2 | ||||||||
MIRT697673 | WASL | Wiskott-Aldrich syndrome like | 2 | 2 | ||||||||
MIRT697716 | VKORC1L1 | vitamin K epoxide reductase complex subunit 1 like 1 | 2 | 2 | ||||||||
MIRT699719 | SESTD1 | SEC14 and spectrin domain containing 1 | 2 | 2 | ||||||||
MIRT701220 | OGDH | oxoglutarate dehydrogenase | 2 | 2 | ||||||||
MIRT701436 | NFYA | nuclear transcription factor Y subunit alpha | 2 | 2 | ||||||||
MIRT701554 | NANOS1 | nanos C2HC-type zinc finger 1 | 2 | 2 | ||||||||
MIRT707559 | CLVS2 | clavesin 2 | 2 | 2 | ||||||||
MIRT707925 | PPP1R3D | protein phosphatase 1 regulatory subunit 3D | 2 | 2 | ||||||||
MIRT711148 | NAA15 | N(alpha)-acetyltransferase 15, NatA auxiliary subunit | 2 | 2 | ||||||||
MIRT719256 | CD44 | CD44 molecule (Indian blood group) | 2 | 2 | ||||||||
MIRT719810 | TXNDC17 | thioredoxin domain containing 17 | 2 | 2 | ||||||||
MIRT722650 | SIGLEC14 | sialic acid binding Ig like lectin 14 | 2 | 2 | ||||||||
MIRT723901 | PEX11A | peroxisomal biogenesis factor 11 alpha | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|